What is Tower Laboratories?
Tower Laboratories, Ltd. operates as a premier contract manufacturer specializing in the development and production of effervescent delivery systems. The company serves as the leading supplier of store-brand effervescent products, including denture cleansers, antacid and pain relief solutions, and cold relief medications. Beyond its proprietary product lines, the firm provides comprehensive end-to-end development services for prescription and over-the-counter (OTC) drugs, dietary supplements, and medical devices. Operating out of multiple facilities in Connecticut and Michigan, the company integrates advanced chemical engineering with a customer-centric partnership model to deliver cost-efficient, stable, and high-quality solutions for a diverse client base.
How much funding has Tower Laboratories raised?
Tower Laboratories has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Tower Laboratories
PPP
Public-Private Partnership
What's next for Tower Laboratories?
Looking ahead, the strategic deployment of the $2M will likely focus on enhancing the company's core competencies in effervescent technology and expanding its commercialization pipeline. As the demand for innovative drug delivery systems grows, Tower Laboratories is poised to capitalize on its competitive advantage in intellectual property and manufacturing efficiency. The firm's commitment to environmentally and socially responsible operations, combined with its robust infrastructure, suggests a future defined by sustained market leadership and potential expansion into new specialty application categories. By deepening its integration within the supply chains of major retail and pharmaceutical partners, Tower Laboratories is set to reinforce its status as an indispensable player in the global health and wellness manufacturing ecosystem.
See full Tower Laboratories company page
